At EyeDPharma, we engage with both KOLs and patient associations from the very early stages of development to ensure we fully understand the needs of our payers, clinicians, and, most importantly, patients. In this presentation you will learn:

• Concrete examples of our early-phase patient engagement initiatives at EyeDPharma.
• The key benefits and insights gained from incorporating patient perspectives from the start.
• The challenges, limitations, and obstacles encountered within the company, including the risk of conflicts of interest.
• The tools and resources available to support this approach, such as EUPATI guidelines and other best practices.